Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs

Journal of Bone and Mineral Metabolism

Volumn 22, Issue 1, 2004, Pages 53-57

  Di Stefano, Marco ^a   Chiabotto, Patrizia ^c   Roggia, Cristiana ^a   Garofalo, Franco ^b   Lala, Roberto ^c   Piga, Antonio ^b   Isaia, Giovanni Carlo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

Author keywords

Bone mineral density; Deferiprone; Desferrioxamine; Dual X ray absorptiometry; Thalassemia

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; IRON CHELATING AGENT;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IRON CHELATION; LUMBAR SPINE; MALE; PREPUBERTY; PRIORITY JOURNAL; THALASSEMIA;

ADOLESCENT; ALKALINE PHOSPHATASE; AMINO ACIDS; BODY WEIGHTS AND MEASURES; BONE AND BONES; BONE DENSITY; CHILD; DEFEROXAMINE; FEMALE; FEMUR; FERRITINS; HUMANS; IRON CHELATING AGENTS; LUMBAR VERTEBRAE; MALE; PROSPECTIVE STUDIES; PYRIDONES; THALASSEMIA; TIME FACTORS;

EID: 0942266061     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-003-0449-z     Document Type: Article

References (23)

1. Soliman AT, El Banna N, Abdel Fattah M, El Zalabani MM, Ansari BM (1998) Bone mineral density in prepubertal children with beta-thalassemia: correlation with growth and hormonal data. Metabolism 47:541-548
2. Giuzio E, Bria M, Bisconte MG, Caracciolo M, Qualtieri A, Misasi M, Grillo G, Brancati C (1991) Osteoporosis in patients affected with thalassaemia. Our experience. Chir Organi Mov LXXVI:369-374
3. de Vernejoul MC, Girot R, Geuris J, Cancela L. Bangs S, Bielakoft J, Mantalen C, Goldberg D, Miravet L (1982) Calcium phosphate metabolism and bone disease in patients with homozygous thalassemia. J Clin Endocr Metab 54:276-281
4. Orvieto R, Leichter I, Rachmilewitz EA, Marguries JY (1992) Bone density, mineral content, and cortical index in patients with thalassaemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine. Calcif Tissue Int 50:397-399
5. Finsterbush A, Ferber I, Mogle P, Goldfarb A (1985) Fracture patterns in thalassemia. Clin Orthop Rel Res 192:132-136
6. Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P (1995) The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches. Clin Endocrinol 42:279-287
7. Brandle M, Galeazzi RL, Morant R, Oesterle M (1996) Osteopenia in beta-thalassemia major. Schweiz Med Wochenschr 126:1867-1874
8. Tolis G, Papandreou A, Karydis I (1997) Amenorrhea in beta-homozygous thalassemia major. Ann N Y Acad Sci 816:274-279
9. Pootrakul P, Hungspringes S, Fucharoen S, Baylink D, Thompson E, English E, Lee M, Burnell J, Finch C (1981) Relation between erythropoiesis and bone metabolism and thalassemia. N Engl J Med 304:1470-1473
10. Diamond T, Stiel D, Posen S (1989) Osteoporosis in haemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Int Med 110:430-436
11. de Vernejoul MC, Pontillart A, Cywiner C, Morieux C, Bielakoff J, Modrowski D, Miravet L (1984) Effects of iron overload on bone remodelling in pigs. Am J Pathol 116:377-384
12. Monnier LH, Colette C, Ribot C, Mion C, Mirouze J (1980) Evidence for 25-hydroxyvitamin D deficiency as a factor contributing to osteopenia in diabetic patients with idiopathic haemochromatosis. Eur J Clin Invest 10:183-187
13. Chow LH, Frei JV, Hodsman AA, Valberg LS (1985) Low serum 25-hydroxyvitamin D in hereditary haemochromatosis: relation to iron status. Gastroenterology 88:865-869
14. Olivieri NF, Koren G, Harris J, Khattak S, Freedman MH. Templeton DM, Bailey JD, Reilly BJ (1992) Growth failure and bone changes induced by deferoxamine. Am J Pediatr Hematol Oncol 14:48-56
15. Pantelakis S, Rodda CR (1994) Endocrine aspects of thalassaemia major. Acta Paediatr 406:105-106
16. Pawlotsky Y, Roussey M, Hany Y, Simon M, Bourel M (1974) Hyperparathormonemie dans l'hemochromatose idiopathique. Nouv Presse Med 3:1757-1758
17. Tanner JM (1962) Growth at Adolescence, 2nd edn. Blackwell, Oxford
18. Glastre C, Braillon P, David L, Cochat P, Meunier PJ, Delmas PD (1990) Measurement of bone mineral content of the lumbar spine by dual energy X-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab 70:1330-1333
19. Faulkner RA, Bailey DA, Drinkwater DT, McKay HA, Arnold C, Wilkinson AA (1996) Bone densitometry in Canadian children 8-17 years of age. Calcif Tissue Int 59:344-351
20. Moreira-Andres MN, Canizo FJ, Papapietro K, Rejas J, Hawkins FG (1995) Comparison between spinal and radial bone mineral density in children measured by X-ray absorptiometry. J Pediatr Endocrinol Metab 8:35-41
21. Zanchetta JR, Plotkin H, Alvarez Filgueira ML (1995) Bone mass in children: normative values for the 2- to 20-year-old population. Bone 16:393S-399S
22. Lu PW, Briody JN, Ogle GD, Morley K, Humphries IR, Allen J (1994) Bone mineral density of total body, spine and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res 9:1451-1458
23. Sabatier JP, Guaydier-Souquieres G, Laroche D, Benmalek A, Fournier L, Guillon-Metz F (1996) Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age. Osteoporosis Int 6:141-148